Emcure Pharmaceuticals Limited (BOM:544210)

Emcure Pharmaceuticals Statistics

Total Valuation

BOM:544210 has a market cap or net worth of INR 263.97 billion. The enterprise value is 276.86 billion.

Market Cap	263.97B
Enterprise Value	276.86B

Important Dates

The last earnings date was Tuesday, November 11, 2025.

Earnings Date	Nov 11, 2025
Ex-Dividend Date	Aug 14, 2025

Share Statistics

Current Share Class	189.56M
Shares Outstanding	n/a
Shares Change (YoY)	+3.59%
Shares Change (QoQ)	-0.03%
Owned by Insiders (%)	72.80%
Owned by Institutions (%)	3.94%
Float	25.12M

Valuation Ratios

The trailing PE ratio is 33.28 and the forward PE ratio is 25.82.

PE Ratio	33.28
Forward PE	25.82
PS Ratio	3.12
PB Ratio	5.40
P/TBV Ratio	7.08
P/FCF Ratio	52.03
P/OCF Ratio	35.30
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 17.47, with an EV/FCF ratio of 54.57.

EV / Earnings	34.91
EV / Sales	3.28
EV / EBITDA	17.47
EV / EBIT	23.13
EV / FCF	54.57

Financial Position

The company has a current ratio of 1.52, with a Debt / Equity ratio of 0.34.

Current Ratio	1.52
Quick Ratio	0.79
Debt / Equity	0.34
Debt / EBITDA	1.05
Debt / FCF	3.27
Interest Coverage	14.17

Financial Efficiency

Return on equity (ROE) is 17.84% and return on invested capital (ROIC) is 12.43%.

Return on Equity (ROE)	17.84%
Return on Assets (ROA)	8.54%
Return on Invested Capital (ROIC)	12.43%
Return on Capital Employed (ROCE)	20.98%
Revenue Per Employee	12.55M
Profits Per Employee	1.18M
Employee Count	6,731
Asset Turnover	0.96
Inventory Turnover	1.70

Taxes

In the past 12 months, BOM:544210 has paid 3.03 billion in taxes.

Income Tax	3.03B
Effective Tax Rate	27.01%

Stock Price Statistics

The stock price has increased by +1.08% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+1.08%
50-Day Moving Average	1,363.76
200-Day Moving Average	1,249.69
Relative Strength Index (RSI)	54.17
Average Volume (20 Days)	286,634

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:544210 had revenue of INR 84.49 billion and earned 7.93 billion in profits. Earnings per share was 41.87.

Revenue	84.49B
Gross Profit	50.07B
Operating Income	11.97B
Pretax Income	11.23B
Net Income	7.93B
EBITDA	15.38B
EBIT	11.97B
Earnings Per Share (EPS)	41.87

Balance Sheet

The company has 5.12 billion in cash and 16.59 billion in debt, giving a net cash position of -11.47 billion.

Cash & Cash Equivalents	5.12B
Total Debt	16.59B
Net Cash	-11.47B
Net Cash Per Share	n/a
Equity (Book Value)	48.84B
Book Value Per Share	250.31
Working Capital	19.19B

Cash Flow

In the last 12 months, operating cash flow was 7.48 billion and capital expenditures -2.40 billion, giving a free cash flow of 5.07 billion.

Operating Cash Flow	7.48B
Capital Expenditures	-2.40B
Free Cash Flow	5.07B
FCF Per Share	n/a

Margins

Gross margin is 59.26%, with operating and profit margins of 14.17% and 9.39%.

Gross Margin	59.26%
Operating Margin	14.17%
Pretax Margin	13.29%
Profit Margin	9.39%
EBITDA Margin	18.20%
EBIT Margin	14.17%
FCF Margin	6.00%

Dividends & Yields

This stock pays an annual dividend of 3.00, which amounts to a dividend yield of 0.22%.

Dividend Per Share	3.00
Dividend Yield	0.22%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	7.17%
Buyback Yield	-3.59%
Shareholder Yield	-3.37%
Earnings Yield	3.00%
FCF Yield	1.92%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3